… the SARS-Cov-2 outbreak (4). Different preclinical in vitro and in vivo studies on other
CoV-induced diseases suggested that promising clinical outcomes for SARS-Cov-2 patients …

… , previous use of the drugs, and early findings of possible drug mechanisms. Moreover, our
review would provide insightful evidence for future SARS-CoV-2 research and might support …

… results of preclinical investigations on MOV for SARS-CoV-2 … These findings
suggested that MOV concentration within … of SARS-CoV-2 transmission in some settings [Citation68]. …

… been published on viral kinetics during the preclinical and clinical periods of SARS-CoV-2. …
In our finding, the Ct value is as low as 30 or less from 5 days before symptom onset to 10 …

… Here, we describe the preclinical studies of the first Egyptian inactivated SARS-CoV-2 …
our findings, previous recent studies of Syrian hamsters challenged intranasally with SARS-CoV-2 …

… Hence, the findings of this study prompted us to plan a new in vivo experiment with the
second version of SK-01 and OZG-3861 (1 × 10 13 or 1 × 10 14 viral copies per dose) in …

… Overall, these preclinical findings support further clinical development of Baiya SARS-CoV-…
In the present study, we describe the preclinical evaluation of our second-generation vaccine …

… Figure 6 Histopathological findings in the lungs of hamsters challenged with SARS-CoV-2.
(A) Areas of necrosis with hemorrhage, thickened alveolar wall, and infiltration …

… SARS-CoV-2 shares 79 and 50 per cent genome similarity with SARS-CoV and MERS-CoV,
respectively 1 . Further, SARS-CoV-2 genome shares 96.2 and 87 per cent similarity with …

… , preclinical safety and toxicity of this plant-produced subunit vaccine candidate, Baiya
SARS-CoV… This finding indicates that the Baiya SARS-CoV-2 Vax 1 vaccine adjuvanted with alum-…